+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Artificial Intelligence in Healthcare Diagnosis Market by Component (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Application, End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5206468
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Artificial Intelligence in Healthcare Diagnosis Market size was estimated at USD 2.10 billion in 2023, USD 2.53 billion in 2024, and is expected to grow at a CAGR of 21.23% to reach USD 8.08 billion by 2030.

AI in healthcare diagnosis uses technologies, including ML, to process and analyze data related to medical diagnosis. The ability of artificial intelligence (AI) to quickly process enormous amounts of data, identify patterns, and make more accurate diagnoses promptly than doctors have increased the use of AI in healthcare diagnosis. The growing implementation of artificial intelligence and robotics in the healthcare sector, transfigurating medical science, and accelerating investments by government and private sectors in artificial intelligence, have been promoting the use of AI in healthcare diagnosis. However, the need for more trained professionals, expertise in artificial intelligence, and data privacy concerns about using AI in hospitals and clinics impede their utmost usage. Market players are focused on technological development and privacy updation of AI in imaging & diagnosis to overcome these limitations. By using artificial intelligence in healthcare diagnosis, medical professionals are able to take more informed decisions based on more accurate information while saving time, reducing costs, and improving medical records management.

Regional Insights

Europe is expected to see a vital increase in the use of AI in healthcare diagnosis, characterized by the increasing number of advances in healthcare diagnostic technologies held in the region and AI use initiatives developed by the public healthcare authorities. The Middle East region also witnesses a rise in the establishment of smart hospitals across Saudi Arabia, UAE, and Israel, driving the potential to use AI to diagnose diseases. The Americas is home to many established AI technology providers constantly working on expanding their healthcare knowledge to upgrade their existing portfolio. AI-based diagnostic devices and systems are widely used across the U.S. and Canada to attain real-time and faster results. The Asia-Pacific region observes a slow and steady increase in AI adoption of healthcare diagnosis, with many digital transformation initiatives, healthcare startups, and diagnostic laboratories obtaining new funds for breakthrough diagnostic solutions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Intelligence in Healthcare Diagnosis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Intelligence in Healthcare Diagnosis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Healthcare Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Advanced Micro Devices, Inc, Aidence B.V., Aidoc Medical Ltd., Amazon Web Services, Inc., Apixo, Inc., Appinventiv Technologies Pvt. Ltd., Arterys Inc., Butterfly Network, Inc., Caption Health, Inc., CloudMedx Inc., Day Zero Diagnostics Inc., Digital Diagnostics Inc., EchoNous Inc., Enlitic, Inc, GE HealthCare Technologies Inc., Google LLC, HeartFlow, Inc., Intel Corporation, International Business Machines Corporation, Koninkliike Philips N.V., Lunit Inc., Medtronic PLC, Microsoft Corporation, Nano-X Imaging Ltd., NovaSignal Corporation, Nvidia Corporation, Prognos Health Inc., Siemens Healthcare Private Limited, SolutionChamps Technologies Pvt. Ltd., and Sophia Genetics S A.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Healthcare Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Hardware
    • Services
    • Software
  • Technology
    • Computer Vision
    • Context-Aware Computing
    • Machine Learning
    • Natural Language Processing
  • Application
    • Cardiology
    • Chest & Lung Scanning
    • Neurology
    • Oncology
    • Pathology
    • Radiology
  • End-user
    • Academic Institutions & Research Center
    • Diagnostic Center
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Artificial Intelligence in Healthcare Diagnosis Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Intelligence in Healthcare Diagnosis Market?
  3. What are the technology trends and regulatory frameworks in the Artificial Intelligence in Healthcare Diagnosis Market?
  4. What is the market share of the leading vendors in the Artificial Intelligence in Healthcare Diagnosis Market?
  5. Which modes and strategic moves are suitable for entering the Artificial Intelligence in Healthcare Diagnosis Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Artificial Intelligence in Healthcare Diagnosis Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of artificial intelligence in healthcare research areas
5.1.1.2. Increasing adoption of advanced disease diagnostic solutions
5.1.1.3. Growing potential for AI-based tools and software for the geriatric population
5.1.2. Restraints
5.1.2.1. Shortage of trained professionals and expertise in artificial intelligence for the medical industry
5.1.3. Opportunities
5.1.3.1. Accelerating investments by government and private sectors in artificial intelligence
5.1.3.2. Proliferation in government approvals for AI-based healthcare diagnosis tools
5.1.4. Challenges
5.1.4.1. Concern regarding medical data privacy and the guidelines for regulatory compliance
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Artificial Intelligence in Healthcare Diagnosis Market, by Component
6.1. Introduction
6.2. Hardware
6.3. Services
6.4. Software
7. Artificial Intelligence in Healthcare Diagnosis Market, by Technology
7.1. Introduction
7.2. Computer Vision
7.3. Context-Aware Computing
7.4. Machine Learning
7.5. Natural Language Processing
8. Artificial Intelligence in Healthcare Diagnosis Market, by Application
8.1. Introduction
8.2. Cardiology
8.3. Chest & Lung Scanning
8.4. Neurology
8.5. Oncology
8.6. Pathology
8.7. Radiology
9. Artificial Intelligence in Healthcare Diagnosis Market, by End-user
9.1. Introduction
9.2. Academic Institutions & Research Center
9.3. Diagnostic Center
9.4. Hospitals
10. Americas Artificial Intelligence in Healthcare Diagnosis Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Artificial Intelligence in Healthcare Diagnosis Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Bayer Acquires British Medical Imaging AI Developer Blackford
13.3.1.2. Beckman Coulter Acquires Artificial Intelligence Company Providing Evidence-Based Clinical Decision Support for Emergency Departments
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Microsoft Signs First AI Healthcare Partnership in Vietnam
13.3.2.2. Mayo Clinic Expands Artificial Intelligence-Enabled Diagnostics Partnership
13.3.3. New Product Launch & Enhancement
13.3.3.1. CLIRNET Launches India's First AI-Powered Doctor's Assistant (AiDA)
13.3.3.2. Philips Highlights AI-Powered Integrated Diagnostics at ECR
13.3.4. Investment & Funding
13.3.4.1. UK Government Invests GBP 16 Million in AI Healthcare Technologies to Help Speed Up Diagnostics
13.3.4.2. AI Medical Imaging Startup Qritive Raises USD 7.5 Million in Latest Funding
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Vuno Gets US Patent for AI Medical Image Analysis Technology
13.3.5.2. RadNet Receives FDA Clearance for Cancer Detection Algorithms
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Accenture PLC
14.1.2. Advanced Micro Devices, Inc
14.1.3. Aidence B.V.
14.1.4. Aidoc Medical Ltd.
14.1.5. Amazon Web Services, Inc.
14.1.6. Apixo, Inc.
14.1.7. Appinventiv Technologies Pvt. Ltd.
14.1.8. Arterys Inc.
14.1.9. Butterfly Network, Inc.
14.1.10. Caption Health, Inc.
14.1.11. CloudMedx Inc.
14.1.12. Day Zero Diagnostics Inc.
14.1.13. Digital Diagnostics Inc.
14.1.14. EchoNous Inc.
14.1.15. Enlitic, Inc
14.1.16. GE HealthCare Technologies Inc.
14.1.17. Google LLC
14.1.18. HeartFlow, Inc.
14.1.19. Intel Corporation
14.1.20. International Business Machines Corporation
14.1.21. Koninkliike Philips N.V.
14.1.22. Lunit Inc.
14.1.23. Medtronic PLC
14.1.24. Microsoft Corporation
14.1.25. Nano-X Imaging Ltd.
14.1.26. NovaSignal Corporation
14.1.27. Nvidia Corporation
14.1.28. Prognos Health Inc.
14.1.29. Siemens Healthcare Private Limited
14.1.30. SolutionChamps Technologies Pvt. Ltd.
14.1.31. Sophia Genetics S A
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET RESEARCH PROCESS
FIGURE 2. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, 2023 VS 2030
FIGURE 3. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET DYNAMICS
FIGURE 7. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Accenture PLC
  • Advanced Micro Devices, Inc
  • Aidence B.V.
  • Aidoc Medical Ltd.
  • Amazon Web Services, Inc.
  • Apixo, Inc.
  • Appinventiv Technologies Pvt. Ltd.
  • Arterys Inc.
  • Butterfly Network, Inc.
  • Caption Health, Inc.
  • CloudMedx Inc.
  • Day Zero Diagnostics Inc.
  • Digital Diagnostics Inc.
  • EchoNous Inc.
  • Enlitic, Inc
  • GE HealthCare Technologies Inc.
  • Google LLC
  • HeartFlow, Inc.
  • Intel Corporation
  • International Business Machines Corporation
  • Koninkliike Philips N.V.
  • Lunit Inc.
  • Medtronic PLC
  • Microsoft Corporation
  • Nano-X Imaging Ltd.
  • NovaSignal Corporation
  • Nvidia Corporation
  • Prognos Health Inc.
  • Siemens Healthcare Private Limited
  • SolutionChamps Technologies Pvt. Ltd.
  • Sophia Genetics S A

Methodology

Loading
LOADING...

Table Information